Watson Ferrlecit
Executive Summary
Sodium ferric gluconate injection covered by Medicare as of Dec. 1 as a first-line treatment of iron deficiency anemia in patients undergoing chronic hemodialysis who are receiving supplemental EPO therapy. HCFA issued a National Coverage Decision for the agent on April 20 (1"The Pink Sheet" May 22, p. 25)